Annual report pursuant to Section 13 and 15(d)

Intangible Assets - License Agreements (Details)

v3.19.3.a.u2
Intangible Assets - License Agreements (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Sales and Marketing Expense      
Intangible assets      
Royalty fees included in sales and marketing expense $ 2,119 $ 1,661 $ 1,195
License Agreements      
Intangible assets      
Notice period for termination of license agreements 60 days    
Minimum royalty of agreements $ 13    
Milestone fee upon receiving a Phase II Small Business Innovation Research 15    
Milestone fee upon FDA approval 2    
Milestone fee upon first commercial use of certain licensed technology 25    
Milestone fee upon first use to manufacture products that utilize certain technology not currently incorporated into AxoGen products $ 10    
License Agreements | Minimum      
Intangible assets      
Royalty fees range under the license agreements 1.00%    
License Agreements | Maximum      
Intangible assets      
Royalty fees range under the license agreements 3.00%    
Royalty stack cap for royalties paid to more than one licensor for sales of the same product 3.75%